Tonic-clonic (Grand Mal) Seizure Market Research
Better Target Tonic-clonic (Grand Mal) Seizure Patients through Digital Channels

Manhattan Research presents the Tonic-clonic (Grand Mal) Seizure Segmentation Module as part of its consumer market research and advisory services. The Tonic-clonic (Grand Mal) Seizure Segmentation Module is a comprehensive analysis of the tonic-clonic (grand mal) seizure patient market, giving an in-depth view of this condition group’s adoption and use of the Internet and other technology for health, treatment, and product decisions. Brand teams rely on our tonic-clonic (grand mal) seizure market research for its strategic view of this condition group and its focus on tactical execution.

Key topics include media consumption across traditional and alternative resource channels, website usage metrics, connectivity and interaction with physicians, health site engagement, use of branded and unbranded product sites, Web 2.0, interest in online health services and tools, DTC advertising, actions taken offline after health info seeking, and drivers to requesting a prescription drug.

Our tonic-clonic (grand mal) seizure market research helps brand teams answer questions such as:
  • How much budget should I allocate to marketing to tonic-clonic (grand mal) seizure patients online?
  • What types of technologies are tonic-clonic (grand mal) seizure patients interested in for managing their health?
  • How are tonic-clonic (grand mal) seizure patients interacting with my brand online, and what are they doing after they visit my site?
  • What types of media do tonic-clonic (grand mal) seizure patients use to research health information?
  • How can I ensure that our digital marketing strategies will be effective in reaching tonic-clonic (grand mal) seizure patients?

For information about purchasing the Tonic-clonic (Grand Mal) Seizure Segmentation Module, please contact sales@manhattanresearch.com or call 1.888.680.0800, ext 2.

For the full list of available therapeutic segmentation modules, click here.

| Share on Facebook | Del.icio.us | Digg this | Email This